Literature DB >> 153529

DNA gyrase: subunit structure and ATPase activity of the purified enzyme.

K Mizuuchi, M H O'Dea, M Gellert.   

Abstract

DNA gyrase has been purified to near homogeneity from Escherichia coli. The enzyme consists of two subunits of molecular weights 90,000 and 100,000 present in roughly equimolar amounts. The subunits can be identified as the products of two genes, determining resistance to coumermycin A1 and novobiocin (cou) and to nalidixic acid and oxolinic acid (nalA), respectively. These antibiotics were previously shown to be specific inhibitors of DNA gyrase. The ATPase activity of DNA gyrase is stimulated by double-stranded DNA and strongly inhibited by novobiocin but is relatively insensitive to oxolinic acid. Covalent attachment of an ATP derivative to the smaller (coumermycin-specific) subunit is also inhibited by novobiocin, suggesting that this drug interferes with the energy-coupling aspect of the DNA supercoiling reaction by blocking the access of ATP to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153529      PMCID: PMC393096          DOI: 10.1073/pnas.75.12.5960

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  THE FATE OF NICOTINAMIDE IN THE MOUSE; TISSUE METABOLITES.

Authors:  S CHAYKIN; M DAGANI; L JOHNSON; M SAMLI; J BATTAILE
Journal:  Biochim Biophys Acta       Date:  1965-05-04

2.  Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme.

Authors:  A Sugino; C L Peebles; K N Kreuzer; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

3.  DNA gyrase: an enzyme that introduces superhelical turns into DNA.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

4.  Role of DNA gyrase in phiX replicative-form replication in vitro.

Authors:  K J Marians; J E Ikeda; S Schlagman; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

5.  Supercoiling energy and nucleosome formation: the role of the arginine-rich histone kernel.

Authors:  R D Camerini-Otero; G Felsenfeld
Journal:  Nucleic Acids Res       Date:  1977       Impact factor: 16.971

6.  Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.

Authors:  M Gellert; M H O'Dea; T Itoh; J Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

7.  Pyruvate carboxylase: affinity labelling of the magnesium adenosine triphosphate binding site.

Authors:  S B Easterbrook-Smith; J C Wallace; D B Keech
Journal:  Eur J Biochem       Date:  1976-02-02

8.  Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity.

Authors:  N P Higgins; C L Peebles; A Sugino; N R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

9.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Micrococcus luteus DNA gyrase: active components and a model for its supercoiling of DNA.

Authors:  L F Liu; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

  10 in total
  108 in total

1.  Mutations in the C-terminal domain of topoisomerase II affect meiotic function and interaction with the casein kinase 2 beta subunit.

Authors:  D Leroy; G C Alghisi; E Roberts; O Filhol-Cochet; S M Gasser
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents.

Authors:  J F Barrett; T D Gootz; P R McGuirk; C A Farrell; S A Sokolowski
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

3.  Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.

Authors:  X S Pan; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

4.  Chirality sensing by Escherichia coli topoisomerase IV and the mechanism of type II topoisomerases.

Authors:  Michael D Stone; Zev Bryant; Nancy J Crisona; Steven B Smith; Alexander Vologodskii; Carlos Bustamante; Nicholas R Cozzarelli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

5.  Assessing sensitivity to antibacterial topoisomerase II inhibitors.

Authors:  Sonia K Morgan-Linnell; Hiroshi Hiasa; Lynn Zechiedrich; John L Nitiss
Journal:  Curr Protoc Pharmacol       Date:  2007-12

6.  Characterization of a plasmid mutation affecting maintenance, transfer and elimination by novobiocin.

Authors:  D E Taylor; J G Levine
Journal:  Mol Gen Genet       Date:  1979-07-13

7.  Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus.

Authors:  K Ubukata; N Itoh-Yamashita; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

Authors:  B L Masecar; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.

Authors:  D S Samuels; R T Marconi; W M Huang; C F Garon
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

10.  RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium.

Authors:  A B Blanc-Potard; E Gari; F Spirito; N Figueroa-Bossi; L Bossi
Journal:  Mol Gen Genet       Date:  1995-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.